Now, single tablet to protect your pet against 6 parasites

Elanco Animal Health, Inc., has announced the market availability of Credelio Quattro, a broad spectrum chewable anti-parasite tablet with four established and powerful ingredients. The tablet, which contains lotilaner, moxidectin, praziquantel, and pyrantel, is designed to deliver the broadest protection against parasites—based on label comparison of the number of parasite types covered in a chewable that targets ticks—the company said in a press release. Credelio Quattro is the first and only monthly chewable tablet of...

U.S. FDA clears new Zenrelia tablets to treat itchy dogs

The U.S. Food and Drug Administration last week approved Zenrelia, or ilunocitinib tablets, a new veterinary drug from Elanco Animal Health, Inc., based in Greenfield, Indiana, to control pruritus, or itching, associated with allergic dermatitis and to control atopic dermatitis, or environmental allergies, in dogs that are at least a year old. According to Elanco Animal Health, itching is one of the top reasons pet owners take their dogs to the veterinarian, and pet owners...

Seven tips to keep your pets safe and healthy in the rainy season

With the monsoon having finally set in, the scorching heat of the Indian summer, made worse by climate change and deforestation, is behind us, but pet owners face new challenges in keeping their wards safe and healthy. While the rains bring welcome relief for pets and their owners from the heat and dust, they also bring skin infections and moisture-induced diseases that compromise the animals’ health and hygiene. Here are seven simple tips to follow...

German pharma company introduces broad-spectrum tablet for parasite control in pet dogs

Boehringer Ingelheim, a German family-owned research-driven biopharmaceutical company and global leader in animal health, has announced the launch of NexGard SPECTRA® chewable tablets in India following its approval by the Central Drugs Standard Control Organisation. After the launch of NexGard X and L in 2020 and NexGard S and M (afoxolaner) in 2023, this represents an expansion of the NexGard product line for dogs aged at least two months and weighing 2 kg or more....